发明名称 |
IDENTIFICATION OF PATIENTS WITH ABNORMAL FRACTIONAL SHORTENING |
摘要 |
<p>The present invention relates to a method for assessing whether a subject shall be subjected to an imaging based diagnostic assessment. The method is based on the determination of the amount(s) of a cardiac Troponin and/or Fibroblast Growth Factor 23 (FGF-23) in a sample from the subject, and on the comparison of the, thus, determined amount(s) with a reference amount (reference amounts). The present invention also relates to a system for performing an assessment whether a subject shall be subjected to an imaging based diagnostic assessment and to reagents and kits used in performing the methods disclosed herein. Moreover, the present invention is directed to a method for predicting the risk of mortality and/or of a cardiovascular event. Also encompassed is a method for diagnosing an early stage of LVH in a subject having a preserved left ventricular ejection.</p> |
申请公布号 |
CA2883890(A1) |
申请公布日期 |
2014.03.20 |
申请号 |
CA20132883890 |
申请日期 |
2013.03.28 |
申请人 |
F. HOFFMAN-LA ROCHE AG |
发明人 |
BLOCK, DIRK;MASSON, SERGE;WIENHUES-THELEN, URSULA-HENRIKE;ZAUGG, CHRISTIAN;LATINI, ROBERTO |
分类号 |
G01N33/68 |
主分类号 |
G01N33/68 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|